ArticleClinical ophthalmology (Auckland, N.Z.)2022

Effect of OTX-101 in Patients with Dry Eye Disease at Day 14 of Treatment: Ocular Surface Endpoint Results from the Phase 2b/3 Clinical Trial.

Barry A Schechter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.